SCHEMBL30740968

SCHEMBL30740968

COC(=O)c1cc(OC(F)F)c(O)c([N+](=O)[O-])c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TTR P02766 1/20 0.49
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
RXFP1 Q9HBX9 1/20 0.46
ERN1 O75460 2/20 0.45
VCAM1 P19320 1/20 0.45
MAPT P10636 3/20 0.44
KDM4E B2RXH2 2/20 0.44
ESR1 P03372 1/20 0.43
ALDH1A1 P00352 1/20 0.42
HPGD P15428 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
TPMT P51580 1/20 0.42
LMNA P02545 1/20 0.41
POLB P06746 1/20 0.41
GAA P10253 1/20 0.41
NFKB1 P19838 1/20 0.41
XDH P47989 1/20 0.41
GFER P55789 1/20 0.41
NFKB2 Q00653 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18940575 0.85 VCAM1 (0.44) MEN1KMT2ARXFP1VCAM1MAPT
SCHEMBL30740978 0.85 CASP6 (0.49) TTRERN1MAPTALDH1A1TPMT
SCHEMBL750055 0.84 TTR (0.61) TTRMEN1KMT2ARXFP1ERN1
SCHEMBL29850759 0.84 MAPT (0.43) TTRMEN1KMT2ARXFP1VCAM1
SCHEMBL18940622 0.84 MAPT (0.43) TTRMEN1KMT2ARXFP1VCAM1
SCHEMBL5924211 0.82 ESR1 (0.57) MEN1KMT2ARXFP1ERN1VCAM1
SCHEMBL31003842 0.82 AR (0.54) MEN1KMT2AERN1VCAM1MAPT
SCHEMBL27172514 0.82 ALDH1A1 (0.57) MEN1KMT2AVCAM1MAPTALDH1A1
SCHEMBL3988487 0.82 AR (0.54) MEN1KMT2AERN1VCAM1MAPT
Hydrochloric Acid SCHEMBL9064842 0.81 ESR1 (0.56) MEN1KMT2ARXFP1ERN1VCAM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260035341-A1 FTO INHIBITORS RPXDS CO LTD (CN) 2026-02-05 US disclosed
EP-4561975-A1 FTO INHIBITORS RPXDS Co., Ltd (CN) 2025-06-04 EP disclosed
CN-119546566-A FTO inhibitors 瑞璞鑫(苏州)生物科技有限公司 2025-02-28 CN disclosed
WO-2024022491-A1 FTO INHIBITORS RPXDS CO., LTD (CN) 2024-02-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260035341-A1 FTO INHIBITORS FTO, LDLR, GPR119 TTR 655/4885MEN1 3974/4885KMT2A 567/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.